EFDID: 131994EFD: View Filing

Issuer: ACELRX PHARMACEUTICALS INC (0001427925) - D

Accession: 0001427925-09-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001427925
  • Entity Name:
    ACELRX PHARMACEUTICALS INC
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    575 CHESAPEAKE DRIVE
    REDWOOD CITY, CA 94063
  • Persons:
    Related Persons 11
    Thomas A Schreck
    Executive Officer, Director
    Pamela Palmer
    Executive Officer, Director
    Carter King
    Executive Officer
    Larry Hamel
    Executive Officer
    Anil Dasu
    Executive Officer
    Linda Judge
    Executive Officer
    Mark B Weeks
    Executive Officer
    Howie Rosen
    Director
    Guy Nohra
    Director
    Steve Sullivan
    Director
    Mark Wan
    Director
EDGAR: Offering Information
  • Accession Date:
    11/25/2009
  • First Sale Date:
    11/23/2009
  • Offering Amount:
    $30,000,000
  • Amount Sold:
    $14,814,106
  • Amount Remaining:
    $15,185,894
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ACELRX PHARMACEUTICALS INC/s/ Mark B. WeeksMark B. WeeksSecretary2009-11-24